We showed a moderate PON2 overexpression in pancreas, liver, kidney, and lung tumors and an over 10-fold upregulation of PON2 in thymus tumors and non-Hodgkins lymphomas [23]. The gene discussed is PON2; the disease is thymus neoplasm.